January Clinical News Briefs

February 3, 2015 | The latest news and product releases for clinical IT and trial management:

Cypher Genomics and Sequenom announced a development agreement for next generation noninvasive prenatal tests (NIPT). Sequenom will use Cypher's genome interpretation technology, Mantis, to advance its analysis of clinically relevant fetal sub-chromosomal variants detected in maternal blood. Sub-chromosomal variants represent more than half of rare chromosomal abnormalities, and are more difficult to detect than the aneuploidies commonly covered by NIPT.  Press release 

Oracle introduced Oracle Health Sciences InForm Medication Adherence Insights Cloud Service to track and manage the use of medication during clinical trials. This solution, developed in partnership with Proteus Digital Health, automates data collection and integrates adherence data into an electronic data capture system. It eliminates manual processes for collecting adherence data, such as pill counts and patient questionnaires. Press release 

Novella Clinical, a Quintiles company, and the Cardiovascular Research Foundation (CRF) announced a preferred provider collaboration to offer clinical trial services to developers of cardiovascular drugs and devices, from preclinical to post-market studies. Novella and CRF will offer sponsors access to leading interventional cardiologists, CRFiCOR, the Clinical Trials Center’s cardiovascular imaging laboratories, and Novella’s clinical trial operations services. The service will include protocol development, trial design, statistical analysis, clinical monitoring, and data management. Press release 

goBalto received $12 million in funding from Mitsui Global Investment and Dolby Family Ventures. goBalto will direct the new funding toward continued growth and new software development. The funding round follows a year in which the number of studies started in Activate, goBalto’s flagship study startup platform, tripled. Press release 

3Scan closed a Series A fundraising round of $6.7 million. The financing, led by Lux Capital, will support the continued development of 3Scan’s Knife Edge Scanning Microscope (KESM) technology. KESM automatically sections and images tissue samples to create high-resolution outputs, up to a terabyte per cubic centimeter, which are used to render 3D tissue reconstruction models in an interactive format. KESM can be used to perform quantified image analysis of tissues as thin as a submicron. Press release 

MedNet Solutions announced the latest release of iMedNet eClinical, a cloud-based clinical study management platform. Press release 

ABD Insurance and Financial Services (ABD) announced the addition of new insurance and technology offerings in their Life Science Practice: a Client Portal and Clinical Trial Pac coverage. The Client Portal creates a single source of information across all lines of business in a secure, cloud-based platform, and includes the Clinical Trial Insurance Platform, where clients can review country-specific insurance requirements by clicking on an interactive country map by region. Press release